Ribociclib mitigates cisplatin-associated kidney injury through retinoblastoma-1 dependent mechanisms

Aberrant cell cycle activation is a hallmark of carcinogenesis. Recently three cell cycle targeting cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have been approved for the treatment of metastatic breast cancer. CDK4/6 inhibitors suppress proliferation through inhibition of CDK4/6-dependent retino...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Biochem Pharmacol
Huvudupphovsmän: Kim, Ji Young, Jayne, Laura A., Bai, Yuntao, Feng, Mei Ji He Ho, Clark, Matthew A., Chung, Sangwoon, Christman, John W., Cianciolo, Rachel E., Pabla, Navjot Singh
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7789910/
https://ncbi.nlm.nih.gov/pubmed/32229099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2020.113939
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk